The short version
5 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Arsenic Trioxide
Arsenic Trioxide · ARSENIC TRIOXIDE 1 mg/mL · Injection · Intravenous · Sagent Pharmaceuticals
NDC 25021-0226-10 · 10 VIAL in 1 CARTON / 10 mL in 1 VIAL · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$3,770.00
Reported to Texas DSHS · 2026 annual filing · Sagent Pharmaceuticals
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicare Part B (ASP)
Payment limit per 1 MG
$5.069
HCPCS J9017 · Jul 1, 2026 quarter · typically ASP + 6%
Medicaid spend (2025)
$1,875
67 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA215059
- TE code
- AP
- Approval date
- Oct 7, 2021
- Patents / exclusivity
- None on file
Shortage history
- Planned discontinuation — Arsenic Trioxide, Injection, 1 mg/1 mL (NDC 50742-438-10)Feb 24, 2026
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Arsenic Trioxide (Injection)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Gland Pharma Limited | ARSENIC TRIOXIDE 1 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Gland Pharma Limited | ARSENIC TRIOXIDE 2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Inc | ARSENIC TRIOXIDE 2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Inc | ARSENIC TRIOXIDE 1 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Ingenus Pharmaceuticals, LLC | ARSENIC TRIOXIDE 1 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Nexus Pharmaceuticals LLC | ARSENIC TRIOXIDE 1 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | ARSENIC TRIOXIDE 2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | ARSENIC TRIOXIDE 1 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Arsenic Trioxide — NDC 25021-0226-10," retrieved September 3, 2026, https://drugdashboards.com/drug/25021022610.
Free to cite with attribution — see how the data is put together.